FDA Revokes Emergency Use for COVID-19 Vaccines

Promises Made, Promises Kept: Today Health and Human Services Secretary Robert F. Kennedy, Jr., announced that the Food and Drug Administration (FDA) has officially rescinded the emergency use authorizations (EUAs) for COVID-19 vaccines. The move marks the fulfillment of key campaign promises made by Kennedy to overhaul the nation’s approach to vaccine policy.

Speaking via a post on X, Kennedy outlined his four core commitments: ending COVID-19 vaccine mandates, ensuring vaccine availability for those who want them, requiring placebo-controlled trials from manufacturers, and terminating the emergency status surrounding the vaccines. “Today, through decisive FDA actions, we’ve delivered on all four promises.”

The now-revoked EUAs, which previously enabled widespread vaccine mandates under the Biden administration, have been replaced with targeted marketing authorizations. These authorizations apply to Moderna’s vaccine for individuals aged 6 months and older, Pfizer’s for those 5 and up, and Novavax’s for those 12 and older.

Kennedy emphasized that these vaccines remain accessible to patients who choose them in consultation with their healthcare providers, particularly for those at higher risk.

“This framework prioritizes science, safety, and individual choice,” Kennedy wrote on X. “The American public deserves transparency and common-sense policies, and that’s exactly what we’re delivering.”

Kennedy also expressed gratitude to FDA Director Marty Makary for his role in steering these changes, praising his leadership in aligning the agency’s actions with public demand for evidence-based health policies.

The decision signals a new chapter in the nation’s COVID-19 response, balancing voluntary access with rigorous scientific standards while moving away from broad emergency measures.

Thank you for your support.

If you appreciate the work we do to spread the good news of Jesus Christ, please consider giving a gift to help us continue this work. Maranatha!